Robert DeLuccia
Chairman
Acurx Pharmaceuticals, Inc. (ACXP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Acurx Pharmaceuticals, Inc. (ACXP) | Executive Chairman | $539,172 | $1,463,430 |
| 2023 | Acurx Pharmaceuticals, Inc. (ACXP) | Executive Chairman | $485,000 | $1,056,436 |
| 2022 | Acurx Pharmaceuticals, Inc. (ACXP) | Executive Chairman | $475,000 | $677,186 |
| 2021 | Acurx Pharmaceuticals, Inc. (ACXP) | Executive Chairman | $363,500 | $4,509,094 |
| 2020 | Acurx Pharmaceuticals, Inc. (ACXP) | Executive Chairman | $277,000 | $617,570 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.